Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
Article first published online: 26 AUG 2005
Copyright © 2005 Movement Disorder Society
Volume 21, Issue 1, pages 9–17, January 2006
How to Cite
Morissette, M., Dridi, M., Calon, F., Tahar, A. H., Meltzer, L. T., Bédard, P. J. and Di Paolo, T. (2006), Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin. Mov. Disord., 21: 9–17. doi: 10.1002/mds.20654
- Issue published online: 13 JAN 2006
- Article first published online: 26 AUG 2005
- Manuscript Accepted: 4 FEB 2005
- Manuscript Revised: 2 FEB 2005
- Manuscript Received: 5 NOV 2004
- Canadian Institutes of Health Research
- Novartis Canada and the Neuroscience Foundation
- Fonds de la recherche en santé du Quebec
- Government of Tunisia
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.